The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

iCo Therapeutics Inc

Venture: ICO
Delayed quote

$0.04

Today's change-0.01 -11.11%
Updated November 27 9:46 AM EST. Delayed by at least 15 minutes.
 

iCo Therapeutics Inc

Venture: ICO
Delayed quote

$0.04

Today's change-0.01 -11.11%
Updated November 27 9:46 AM EST. Delayed by at least 15 minutes.

iCo Therapeutics Inc crosses below 50-day moving average

iCo Therapeutics Inc closed sharply lower Thursday, dropping $0.01 or 11.11% to $0.04 and crossing below its 50-day moving average. Over the last five days, shares have gained 14.29%, but are down 89.19% for the last year to date. Shares have underperformed the S&P TSX by 100.25% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.08
Updated November 27 9:46 AM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2014Q1/2014Q4/2013Q3/2013
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013Sep 30, 201309/30/2013
Revenue--------
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense1112
Selling / general / administrative1000
Research & development0111
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total0000
Operating income-1-1-1-2
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-1-1-1-2
Income after tax-1-1-1-2
Income tax, total0000
Net income-1-1-1-2
Total adjustments to net income--------
Net income before extra. items-1-1-1-2
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1-1-1-2
Inc. avail. to common incl. extra. items-1-1-1-2
Diluted net income-1-1-1-2
Dilution adjustment--000
Diluted weighted average shares74687258
Diluted EPS excluding extraordinary itemsvalue per share-0.02-0.01-0.02-0.03
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.02-0.01-0.02-0.03